Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 31, 2017
[ Mon, Jul 31st 2017
] - WOPRAI
[ Mon, Jul 31st 2017
] - WOPRAI
[ Mon, Jul 31st 2017
] - WOPRAI
[ Mon, Jul 31st 2017
] - WOPRAI
[ Mon, Jul 31st 2017
] - WOPRAI
Fri, July 28, 2017
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
Stephen Brozak Downgraded (CDTX) to Strong Sell on, Jul 28th, 2017
Stephen Brozak of WBB Securities, Downgraded "Cidara Therapeutics, Inc." (CDTX) to Strong Sell on, Jul 28th, 2017.
Stephen has made no other calls on CDTX in the last 4 months.
There are 3 other peers that have a rating on CDTX. Out of the 3 peers that are also analyzing CDTX, 0 agree with Stephen's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Stephen
- Laura Chico of "Raymond James" Initiated at Strong Buy and Held Target at $280 on, Friday, April 21st, 2017
- Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $280 on, Monday, April 17th, 2017
- Kevin DeGeeter of "Ladenburg Thalmann" Initiated at Strong Buy and Held Target at $225 on, Wednesday, April 12th, 2017
